Correction to: The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man

Charlie Bridgewood¹, Adewonuola Alase², Abdulla Watad^{2

3

4}, Miriam Wittmann^{2

5}, Richard Cuthbert², Dennis McGonagle^{2

5}

Affiliations

¹ Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, Leeds, UK. medcbri@leeds.ac.uk.
² Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, Leeds, UK.
³ Department of Medicine "B", Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
⁴ Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
⁵ National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC), Leeds Teaching Hospitals, Leeds, UK.

Published Erratum

Charlie Bridgewood et al. Inflamm Res. 2019 Jun.

. 2019 Jun;68(6):427.

doi: 10.1007/s00011-019-01242-y.

Charlie Bridgewood¹, Adewonuola Alase², Abdulla Watad^{2

3

4}, Miriam Wittmann^{2

5}, Richard Cuthbert², Dennis McGonagle^{2

5}

¹ Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, Leeds, UK. medcbri@leeds.ac.uk.
² Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, Leeds, UK.
³ Department of Medicine "B", Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
⁴ Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
⁵ National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC), Leeds Teaching Hospitals, Leeds, UK.

Abstract

The original article can be found online.

The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man.
Bridgewood C, Alase A, Watad A, Wittmann M, Cuthbert R, McGonagle D. Bridgewood C, et al. Inflamm Res. 2019 Jun;68(6):423-426. doi: 10.1007/s00011-019-01235-x. Epub 2019 Apr 13. Inflamm Res. 2019. PMID: 30989239 Free PMC article.